Interesting PB, ratio 30:1 sounds allright.
Another dual listed entity that I follow, SSN, did a 20:1 on the ADR's a few years back.
So for a 30:1 ratio, PRR could end up with apprx 27mil shares at say 39.5c*30 = A$11.85.
Then factor in the exchange rate fluctuations to that. So with the AUD @ $1.05, this could be worth US$12.5.
This may all change when they'll get closer to the remaining results + FDA approval.
Safe to say PRR may now need to update a new broker report on their website, the one frm Feb seems a bit outdated.
http://www.primabiomed.com.au/investor/
Well done to the sub-10c holders.
Interesting PB, ratio 30:1 sounds allright. Another dual listed...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.020(7.41%) |
Mkt cap ! $418.1M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 29.5¢ | 27.0¢ | $1.138M | 3.985M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 63444 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 65000 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |